School of Traditional Chinese Medicine & Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing, China.
J Ethnopharmacol. 2022 Jun 12;291:115157. doi: 10.1016/j.jep.2022.115157. Epub 2022 Mar 2.
The incidence and mortality of bronchial asthma are increasing, and respiratory syncytial virus (RSV) is widely regarded as the common cause of clinical exacerbation of asthma. Ma-Xing-Gan-Shi decoction (MXGSD), a classic traditional Chinese medicine prescription, is well-known for treating respiratory diseases, while the mechanism of effecting on RSV-exacerbated asthma remains to be explored.
In this study, we investigated the mechanism by which MXGSD exerts a protective effect on asthma exacerbated by RSV in vivo and in vitro.
MXGSD is composed of four Chinese medicine, including Ephedra intermedia Schrenk & C.A.Mey. (herbaceous stem, 27g), Prunus armeniaca L. (dry seed, 27g), Glycyrrhiza uralensis Fisch. (radix and rhizome, 18g), and Gypsum fibrosum (main component: CaSO·2HO, 54g). In the present study, the exacerbated asthmatic mice model with the treatment of OVA plus RSV was replicated, and accompanied by the TMT proteomic analysis and further experimental investigations. Then, the protective effect of MXGSD (13.2, 6.6, 3.3 g/kg/d, 7d) on the mice treated by OVA plus RSV, and the mechanism of regulating TRPV1 was explored. In addition, the intracellular Ca concentration of 16HBE cells pretreated with MXGSD medicated serum was also tested after stimulation with the TRPV1 agonist capsaicin.
The results suggested that MXGSD could reduce the levels of inflammation cells, airway hyperresponsiveness, and pathological damage of lung tissue. TMT quantitative proteomics analysis and further experimental exploration revealed that MXGSD could reduce the levels of IL-4, IL-13, PGE, and SP in BAL and down-regulate the expression of TRPV1 mRNA and protein in lung tissue. Furthermore, 16HBE cells stimulated by capsaicin showed an increased intracellular Ca concentration, while the pretreatment of MXGSD medicated serum could reduce it.
MSGSD showed a protective effect on RSV-exacerbated asthma, which may be related to its regulation of TRPV1 expression and reduction of Th2 cytokines and neurogenic inflammatory mediators. It may provide an objective basis and reference for the clinical application of MXGSD.
支气管哮喘的发病率和死亡率正在上升,呼吸道合胞病毒(RSV)被广泛认为是哮喘临床恶化的常见原因。麻杏石甘汤(MXGSD)是一种经典的中药方剂,以治疗呼吸系统疾病而闻名,而其对 RSV 加重哮喘的作用机制仍有待探索。
本研究旨在体内和体外探讨 MXGSD 对 RSV 加重哮喘的保护作用机制。
麻杏石甘汤由麻黄、苦杏仁、炙甘草、石膏四味中药组成。本研究复制了 OVA 加 RSV 处理的哮喘加重小鼠模型,并进行了 TMT 蛋白质组学分析和进一步的实验研究。然后,探讨了 MXGSD(13.2、6.6、3.3 g/kg/d,7d)对 OVA 加 RSV 处理的小鼠的保护作用及其调节 TRPV1 的机制。此外,还检测了 MXGSD 含药血清预处理 16HBE 细胞后,TRPV1 激动剂辣椒素刺激引起的细胞内 Ca 浓度。
结果表明,MXGSD 可降低炎症细胞、气道高反应性和肺组织病理损伤水平。TMT 定量蛋白质组学分析和进一步的实验探索表明,MXGSD 可降低 BAL 中 IL-4、IL-13、PGE 和 SP 的水平,并下调肺组织中 TRPV1 mRNA 和蛋白的表达。此外,辣椒素刺激的 16HBE 细胞细胞内 Ca 浓度增加,而 MXGSD 含药血清预处理可降低其浓度。
MXGSD 对 RSV 加重哮喘具有保护作用,可能与其调节 TRPV1 表达、降低 Th2 细胞因子和神经源性炎症介质有关。为 MXGSD 的临床应用提供了客观依据和参考。